Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Chambers

Showing results (101-110 of 132) with videos related to

Pageof 14
Sort By:
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
Cancer|September 5, 2020
Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neckCielito C Reyes-Gibby, Jian Wang, Liangliang Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2015
Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristicsStephen R Grant, David R Grosshans, Stephen D Bilton, et al.
Journal of Medicinal Chemistry|March 8, 2002
6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A alpha5 receptor inverse agonistsMark S Chambers, John R Atack, Frances A Bromidge, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2005
Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABA(A) alpha5 inverse agonist for cognitive dysfunctionPhilip Jones, John R Atack, Matthew P Braun, et al.
Head & Neck|March 16, 2007
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Head & Neck|January 27, 2022
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivorsPuja Aggarwal, Katherine A Hutcheson, Ryan P Goepfert, et al.
Cancer|August 6, 2021
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivorsPuja Aggarwal, Katherine A Hutcheson, Adam S Garden, et al.
Oral Oncology|March 3, 2017
Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysisAngela T T Wong, Stephen Y Lai, G Brandon Gunn, et al.
Pageof 14

Showing results (101-110 of 132) with videos related to

Sort By:
Pageof 14
Clinical and Translational Radiation Oncology|August 25, 2021
Factors associated with complex oral treatment device usage in patients with head and neck cancerStephen Palasi, Ning Zhang, Mikaela Bankston, et al.
Cancer|September 5, 2020
Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neckCielito C Reyes-Gibby, Jian Wang, Liangliang Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 2, 2015
Proton versus conventional radiotherapy for pediatric salivary gland tumors: Acute toxicity and dosimetric characteristicsStephen R Grant, David R Grosshans, Stephen D Bilton, et al.
Journal of Medicinal Chemistry|March 8, 2002
6,7-Dihydro-2-benzothiophen-4(5H)-ones: a novel class of GABA-A alpha5 receptor inverse agonistsMark S Chambers, John R Atack, Frances A Bromidge, et al.
International Journal of Radiation Oncology, Biology, Physics|May 27, 2008
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2005
Pharmacokinetics and metabolism studies on (3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy) pyrazolo[1,5-d][1,2,4]triazine, a functionally selective GABA(A) alpha5 inverse agonist for cognitive dysfunctionPhilip Jones, John R Atack, Matthew P Braun, et al.
Head & Neck|March 16, 2007
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal, Tito R Mendoza, Mark S Chambers, et al.
Head & Neck|January 27, 2022
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivorsPuja Aggarwal, Katherine A Hutcheson, Ryan P Goepfert, et al.
Cancer|August 6, 2021
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivorsPuja Aggarwal, Katherine A Hutcheson, Adam S Garden, et al.
Oral Oncology|March 3, 2017
Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysisAngela T T Wong, Stephen Y Lai, G Brandon Gunn, et al.
Pageof 14